Eyenovia Inc (NAS:EYEN)
$ 0.77 0 (0%) Market Cap: 41.48 Mil Enterprise Value: 50.14 Mil PE Ratio: 0 PB Ratio: 19.25 GF Score: 21/100

Eyenovia Inc at Cantor Fitzgerald Global Healthcare Conference Transcript

Sep 26, 2023 / 05:00PM GMT
Release Date Price: $1.64 (+4.46%)
Jennifer Kim Cantor Fitzgerald;Analyst

Okay. Good afternoon, everyone. Welcome to the Cantor Global Healthcare Conference. We're going to start our next panel.

I'm Jennifer Kim, a research analyst here at Cantor. I'm looking forward to hosting Eyenovia, Ocugen, and Tarsier Pharma for this ocular-themed panel. So thank you to all three of you for coming.

Michael Rowe Eyenovia
Inc. - CEO

Thank you.

Shankar Musunuri Ocugen
Inc. - Chairman of the Board, CEO, & Co-Founder

Thank you for having us.

Jennifer Kim Cantor Fitzgerald;Analyst

Maybe we could start off -- maybe we could go in a straight line. Could you introduce yourselves and give a brief overview of your company? So I guess, Shankar, we can start with you.

Shankar Musunuri Ocugen
Inc. - Chairman of the Board, CEO, & Co-Founder

Shankar Musunuri, Chairman and CEO, Co-Founder, Ocugen. We're a patient-centric biotech company focused on gene

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot